BLUEBIRD BIO INC (BLUE) Stock Cash Flow
NASDAQ:BLUE - Nasdaq - US09609G1004 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -300.52M | -211.91M | -266.58M | -819.38M | -618.70M | |||
| Depreciation Amortization | 72.74M | 28.52M | 5.00M | 19.65M | 19.36M | |||
| Change In Working Capital | -109.47M | -48.11M | -39.12M | 17.99M | -28.85M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Taxes Paid | -62.00K | -42.00K | 250.00K | 620.00K | 360.00K | |||
| Other non cash items | 113.56M | -3.55M | -52.25M | 146.11M | 157.84M | |||
| OPERATING CASH FLOW | -223.69M | -235.05M | -352.95M | -635.64M | -470.35M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -7.33M | -9.06M | -13.21M | -23.00M | -28.99M | |||
| Other Investing Activity | 12.54M | 164.01M | 263.66M | 585.56M | -55.36M | |||
| INVESTING CASH FLOW | 5.22M | 154.95M | 250.45M | 562.56M | -84.35M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -54.37M | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 120.79M | 248.09M | 54.25M | 80.33M | 546.72M | |||
| Other Financing Activity | N/A | 2.52M | 0.00 | -174.28M | N/A | |||
| FINANCING CASH FLOW | 118.76M | 196.25M | 54.25M | -93.95M | 546.72M | |||
| CHANGE IN CASH | -99.71M | 116.15M | -48.25M | -167.03M | -7.98M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -223.69M | -235.05M | -352.95M | -635.64M | -470.35M | |||
| Capital Expenditure | -7.33M | -9.06M | -13.21M | -23.00M | -28.99M | |||
| FREE CASH FLOW | -231.02M | -244.10M | -366.16M | -658.64M | -499.34M | |||
All data in USD